Prospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10595-10603
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Table 1 Comparison of the baseline conditions between the two groups
Baseline
Remimazolam group (n = 40)
Propofol group (n = 40)
t/χ2 value
P value
Age (yr)54.9 ± 8.552.7 ± 7.01.264 0.210
BMI (kg/m2)24.1 ± 2.423.9 ± 2.20.389 0.699
Systolic blood pressure (mmHg)126.3 ± 6.3124.8 ± 8.10.925 0.358
Diastolic blood pressure (mmHg)75.7 ± 6.076.5 ± 7.3-0.535 0.594
Heart rate (times/min)76.7 ± 7.178.2 ± 7.7-0.906 0.368
Blood glucose (mmol/L)5.39 ± 0.515.50 ± 0.48-0.993 0.324
Gender, n (%)1.270 0.260
Male25 (62.50)20 (50.00)
Female15 (37.50)20 (50.00)
ASA grades, n (%)1.868 0.393
Grade I8 (20.00)6 (15.00)
Grade II20 (50.00)26 (65.00)
Grade III12 (30.00)8 (20.00)